Journal article
ASO Author Reflections: Indolent Growth and Small Bowel Neuroendocrine Tumor Management
Annals of surgical oncology, Vol.28(5), pp.2752-2753
05/01/2021
DOI: 10.1245/s10434-021-09641-4
PMCID: PMC8610082
PMID: 33566244
Abstract
Surgical treatment is central to management of small bowel neuroendocrine tumors (SBNETs). Current controversies include whether to resect asymptomatic primary tumors in the setting of unresectable metastases, the role of minimally invasive surgery, and how best to incorporate/sequence medical treatments. Low SBNET incidence, long event-times, and variability in disease burden, surgical technique, and institutional treatment preferences remain obstacles to conducting randomized surgical trials for SBNETs. With increasing referral of these patients to high-volume centers, cooperation between experienced SBNET clinicians should allow design of high-quality randomized trials to test new treatments and answer key questions.
Details
- Title: Subtitle
- ASO Author Reflections: Indolent Growth and Small Bowel Neuroendocrine Tumor Management
- Creators
- S. K. Sherman - Roy J. and Lucille A. Carver College of MedicineC. G. Tran - Roy J. and Lucille A. Carver College of MedicineJ. R. Howe - Roy J. and Lucille A. Carver College of Medicine
- Resource Type
- Journal article
- Publication Details
- Annals of surgical oncology, Vol.28(5), pp.2752-2753
- DOI
- 10.1245/s10434-021-09641-4
- PMID
- 33566244
- PMCID
- PMC8610082
- NLM abbreviation
- Ann Surg Oncol
- ISSN
- 1068-9265
- eISSN
- 1534-4681
- Publisher
- Springer Nature
- Number of pages
- 2
- Grant note
- T32 CA148062; T32 CA078586 / NIH; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA
- Language
- English
- Date published
- 05/01/2021
- Academic Unit
- Surgery
- Record Identifier
- 9984322941102771
Metrics
17 Record Views